Weiner HL - Search Results

1

The role of the CD58 locus in multiple sclerosis.

De Jager PL, Baecher-Allan C, Maier LM, Arthur AT, Ottoboni L, Barcellos L, McCauley JL, Sawcer S, Goris A, Saarela J, Yelensky R, Price A, Leppa V, Patterson N, de Bakker PI, Tran D, Aubin C, Pobywajlo S, Rossin E, Hu X, Ashley CW, Choy E, Rioux JD, Pericak-Vance MA, Ivinson A, Booth DR, Stewart GJ, Palotie A, Peltonen L, Dubois B, Haines JL, Weiner HL, Compston A, Hauser SL, Daly MJ, Reich D, Oksenberg JR, Hafler DA. De Jager PL, et al. Among authors: weiner hl. Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5264-9. doi: 10.1073/pnas.0813310106. Epub 2009 Feb 23. Proc Natl Acad Sci U S A. 2009. PMID: 19237575 Free PMC article.

2

IL-18 is linked to raised IFN-gamma in multiple sclerosis and is induced by activated CD4(+) T cells via CD40-CD40 ligand interactions.

Karni A, Koldzic DN, Bharanidharan P, Khoury SJ, Weiner HL. Karni A, et al. Among authors: weiner hl. J Neuroimmunol. 2002 Apr;125(1-2):134-40. doi: 10.1016/s0165-5728(02)00018-8. J Neuroimmunol. 2002. PMID: 11960649

3

Cyclophosphamide modulates CD4+ T cells into a T helper type 2 phenotype and reverses increased IFN-gamma production of CD8+ T cells in secondary progressive multiple sclerosis.

Karni A, Balashov K, Hancock WW, Bharanidharan P, Abraham M, Khoury SJ, Weiner HL. Karni A, et al. Among authors: weiner hl. J Neuroimmunol. 2004 Jan;146(1-2):189-98. doi: 10.1016/j.jneuroim.2003.10.036. J Neuroimmunol. 2004. PMID: 14698862

4

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis.

Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA. Viglietta V, et al. Among authors: weiner hl. J Exp Med. 2004 Apr 5;199(7):971-9. doi: 10.1084/jem.20031579. J Exp Med. 2004. PMID: 15067033 Free PMC article.

5

Immunosuppressive treatment in multiple sclerosis.

Weiner HL. Weiner HL. J Neurol Sci. 2004 Aug 15;223(1):1-11. doi: 10.1016/j.jns.2004.04.013. J Neurol Sci. 2004. PMID: 15261554

6

PD-1 ligands, negative regulators for activation of naive, memory, and recently activated human CD4+ T cells.

Cai G, Karni A, Oliveira EM, Weiner HL, Hafler DA, Freeman GJ. Cai G, et al. Among authors: weiner hl. Cell Immunol. 2004 Aug;230(2):89-98. doi: 10.1016/j.cellimm.2004.09.004. Cell Immunol. 2004. PMID: 15598424

7

Immunosuppressive therapy for multiple sclerosis.

Gauthier SA, Buckle GJ, Weiner HL. Gauthier SA, et al. Among authors: weiner hl. Neurol Clin. 2005 Feb;23(1):247-72, viii-ix. doi: 10.1016/j.ncl.2004.09.007. Neurol Clin. 2005. PMID: 15661097 Review. No abstract available.

8

Natalizumab: immune effects and implications for therapy.

Hauser SL, Weiner HL. Hauser SL, et al. Among authors: weiner hl. Ann Neurol. 2006 May;59(5):731-2. doi: 10.1002/ana.20877. Ann Neurol. 2006. PMID: 16634007 No abstract available.

9

Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response.

Karni A, Abraham M, Monsonego A, Cai G, Freeman GJ, Hafler D, Khoury SJ, Weiner HL. Karni A, et al. Among authors: weiner hl. J Immunol. 2006 Sep 15;177(6):4196-202. doi: 10.4049/jimmunol.177.6.4196. J Immunol. 2006. PMID: 16951385

10

A model for the comprehensive investigation of a chronic autoimmune disease: the multiple sclerosis CLIMB study.

Gauthier SA, Glanz BI, Mandel M, Weiner HL. Gauthier SA, et al. Among authors: weiner hl. Autoimmun Rev. 2006 Oct;5(8):532-6. doi: 10.1016/j.autrev.2006.02.012. Epub 2006 Mar 22. Autoimmun Rev. 2006. PMID: 17027888 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

825 results

Search Page